Director, Digitized Case Processing & Digital Adverse Event Interfaces

Working with Us

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients and the careers of those who do it.

You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more:

The purpose of this role is to ensure consistent global leadership for key R&D Quality processes within WWPS, focusing on all aspects of individual case safety reporting (ICSR) processes. The Process Lead (PL) drives initial process optimization and improvement using standard methodology, ensures resources are aligned at the team level, and leads optimization to align with the GVP document hierarchy. The PL serves as the key point of contact for assigned processes, ensures role definition and clarity on key accountabilities, establishes, tracks, and trends process metrics to achieve Quality Outcomes, and leads Community of Practice with Local Process Owner (LPO), other Process Leads (PL), and Subject Matter Experts (SME).

The PL reports into the Global Process Owner (GPO) who provides high-level oversight and decision making in optimizing and sustaining the process. The GPO is the executive oversight and primary decision-maker for assigned processes, endorses metrics to achieve Quality Outcomes, and supports Community of Practice.

At Bristol Myers Squibb, we believe that getting patient safety information right—faster, smarter, and more reliably—is a moral one. Every adverse event we capture more accurately, every process we automate with precision, every AI model we govern responsibly all trace back to a real person whose safety depends on us getting it right.

We’re looking for a Director of Digitized Case Processing & Digital Adverse Event Interfaces—a leader comfortable at the crossroads of pharmacovigilance science, cutting‑edge technology, global regulation, and people leadership.

• Leading the AI‑powered transformation of adverse event intake—defining and owning BMS’s multi‑year digital intake roadmap, deploying AI/NLP, OCR, RPA, LLMs, and Agentic AI to build truly automated, touchless AE case creation workflows within a validated GxP framework.
• Owning the interfaces that connect BMS’s safety ecosystem—from Medical Information and Clinical Development teams to CROs, licensing partners, and regulatory portals like FAERS, Eudra Vigilance, MHRA, and PMDA—driving ICH E2B(R3) electronic exchange adoption and replacing manual transmissions with validated, auditable data pipelines.
• Reinventing how BMS screens medical literature—leading the digital transformation of BMS’s Medical Literature Screening programme, moving to AI/NLP‑driven screening across global databases including Pub Med, EMBASE, Cochrane, and J‑Stage, governing search string development, managing AI classifier calibration, and ensuring audit readiness.
• Building and leading a world‑class global team—guiding a geographically distributed team across the US, UK, Switzerland, India, and Japan, building a culture of psychological safety, scientific rigor, and continuous improvement, defining career pathways, upskilling the team in AI/ML fundamentals, and developing future PV innovation leaders.
• Turning data into decisions—designing and owning the KPI framework for touchless processing rates, intake cycle times, data completeness, literature screening accuracy, and vendor SLA performance; using operational analytics and AI‑generated dashboards to identify…